NR1H4 and cholestasis: SCFAs also modulate the farnesoid X receptor (FXR), a nuclear receptor involved in bile acid synthesis regulation, suggesting a therapeutic potential in conditions such as cholestasis where bile acid homeostasis is disrupted [82].